Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

FDA Approves Avanir’s Nuedexta

By Pharmaceutical Processing | November 1, 2010

The FDA has approved Avanir Pharmaceuticals’ drug for treating a
condition known as pseudobulbar effect — involuntary emotional outbursts
associated with brain disease or injury.

Its shares more than doubled in aftermarket trading, adding
$2.60 to $5.02. The stock had shed 39 cents, or nearly 14 percent, to $2.42
during the regular session.

The drug, dubbed Nuedexta, should be available by
prescription in the first quarter of next year, the company said.

“The approval of Nuedexta also marks Avanir’s
transition toward becoming a commercial enterprise, ready to support the
successful launch of the first FDA-approved treatment for (pseudobulbar
effect),” said Keith Katkin, Avanir’s president and chief executive.

In 2006, the FDA asked for more information on the drug to
consider it for approval. The company started an additional late-stage study on
a low-dose version of the drug in 2007 following an agreement with the agency
and submitted that data earlier this year.

 

 

 

 

Related Articles Read More >

FDA logo
Ultra Supplement announces recall for undeclared tadalafil
analyzing medical sample
Expert answers to nitrosamine impurity questions
Cardinal Health
Cardinal Health announces $124M settlement of investors’ opioid suit
FDA logo
FDA warns four companies over selling honey tainted with prescription drugs

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards